Bo Stentoft ApS: Financial statements 2023
CVR: 35842594
Source: annual report 2023, Danish Business Authority
01/07/2022 – 30/06/2023
Bo Stentoft ApS (CVR 35842594) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 3,483 and a net result of DKK -5,171 compared with DKK 62,308 the year before. That is a decrease of 97.2% compared with the year before. Equity in the 2023 report amounted to DKK -182,837.
- Gross Profit
- DKK 3,483
- Profit/Loss
- DKK -5,171
- Equity
- DKK -182,837
- Total Assets
- DKK 194,935
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 3 t. | -5 t. | -183 t. | - |
| 2022 | - | 127 t. | 62 t. | -178 t. | - |
| 2021 | - | 113 t. | 85 t. | -243 t. | 0 |
| 2020 | - | 299 t. | 57 t. | -327 t. | 1 |
| 2019 | - | 285 t. | 14 t. | -384 t. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
Bo Stentoft ApS has published its annual report for 2022. Gross profit came to DKK 126,540, and the net result was DKK 62,308.
About Bo Stentoft ApS
Bo Stentoft ApS is a Danish company of the type Anpartsselskab based in Køge, founded in 2014. The company is registered under the industry Traditionelle, komplementære og alternative behandlingsformer. The company was previously named Cupping.dk ApS and ACUCARE ApS. The management consists of Bo Stentoft Jensen. The company is owned by Bo Stentoft Jensen. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 683,718 and a net result of DKK 249,774 compared with DKK 52,623 the year before. Equity in the 2025 report amounted to DKK 119,403.